We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
(-49%)
Cap. Flow
-$941M
Cap. Flow
% of AUM
-95.22%
Top 10 Holdings %
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanterix
QTRX
|
+$23.5M |
| 2 |
Outset Medical
OM
|
+$11.4M |
| 3 |
LivaNova
LIVN
|
+$8.76M |
| 4 |
CUTR
Cutera, Inc.
CUTR
|
+$5.89M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$4.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$26.8M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$25.3M |
| 3 |
Biogen
BIIB
|
+$17.4M |
| 4 |
Establishment Labs
ESTA
|
+$15.9M |
| 5 |
VRAY
ViewRay, Inc.
VRAY
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.61% |
| 2 | Industrials | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $68.8M | 6.96% |
168,000
-122,000
| -42% | -$48.7M |
|
2
PUT
iShares S&P 100 ETF
OEF
$20.6B
| $62.4M | 6.32% |
350,000
-200,000
| -36% | -$35.9M |
|
3
PUT
Invesco QQQ Trust
QQQ
$484B
| $59.4M | 6.01% |
185,000
-220,000
| -54% | -$64.9M |
|
4
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
| $58.7M | 5.94% |
1,088,000
-412,000
| -27% | -$26.5M |
|
|
5
Establishment Labs
ESTA
$2.28B
| $48.8M | 4.94% |
720,915
-231,852
| -24% | -$15.9M |
|
6
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
| $45.7M | 4.63% |
425,000
-275,000
| -39% | -$14.4M |
|
|
VRAY
7
DELISTED
ViewRay, Inc.
VRAY
| $31.9M | 3.23% |
9,213,231
-3,335,778
| -27% | -$14.1M |
|
|
CUTR
8
DELISTED
Cutera, Inc.
CUTR
| $28.8M | 2.92% |
1,220,375
+184,354
| +18% | +$5.89M |
|
9
Glaukos
GKOS
$10.6B
| $28.5M | 2.88% |
567,891
-193,158
| -25% | -$9.38M |
|
10
PUT
VanEck Gold Miners ETF
GDX
$27.4B
| $27.2M | 2.75% |
350,000
-50,000
| -13% | -$1.51M |
|
|
11
Quanterix
QTRX
$190M
| $26.6M | 2.69% |
2,362,306
+1,836,165
| +349% | +$23.5M |
|
12
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
| $25.9M | 2.62% |
200,000
-20,000
| -9% | -$2.61M |
|
|
VRAY
13
CALL
DELISTED
ViewRay, Inc.
VRAY
| $23.2M | 2.35% |
6,699,600
+2,999,600
| +81% | +$12.7M |
|
14
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
| $22.9M | 2.31% |
300,000
-270,000
| -47% | -$30.2M |
|
|
15
Inspire Medical Systems
INSP
$1.74B
| $22.2M | 2.25% |
94,893
-106,091
| -53% | -$26.8M |
|
16
PUT
Abbott
ABT
$187B
| $20.3M | 2.05% |
+200,000
| New | +$21.1M |
|
17
PUT
ARK Innovation ETF
ARKK
$6.31B
| $20.2M | 2.04% |
500,000
-725,000
| -59% | -$27.8M |
|
|
18
LivaNova
LIVN
$4.2B
| $17.5M | 1.77% |
400,970
+173,019
| +76% | +$8.76M |
|
19
CALL
Illumina
ILMN
$28.4B
| $17.4M | 1.77% |
77,100
+17,990
| +30% | +$3.68M |
|
20
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
| $17.3M | 1.75% |
575,000
-325,000
| -36% | -$10.1M |
|
|
21
Outset Medical
OM
$90.8M
| $16.9M | 1.71% |
61,276
+30,983
| +102% | +$11.4M |
|
22
CALL
ICU Medical
ICUI
$4.61B
| $16.5M | 1.67% |
100,000
-20,000
| -17% | -$3.44M |
|
23
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
| $15M | 1.51% |
+200,000
| New | +$14.3M |
|
|
NSTG
24
DELISTED
NanoString Technologies, Inc.
NSTG
| $13.1M | 1.33% |
1,326,950
+417,350
| +46% | +$4.13M |
|
25
Natera
NTRA
$46.4B
| $13.1M | 1.33% |
236,430
+71,430
| +43% | +$3.43M |
|
Similar funds
BCA
ONGA
RC
DOFI
SR
SCI
LPC
GBCP
Pura Vida Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.
- Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
- Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
- Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
- Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
- Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
- Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
- Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.
Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.